CD14 and hereditary angioedema: Patients with HAE during attack had significantly higher expression of BR1 on the HLA-DR+CD14+ (37.65%; 25.29–76.03%) comparing to the remission state (29.94%; 19.20–37.60%; p = 0.0003) and healthy subjects (26.19%; 15.31–54.91%; p < 0.0001).